secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGENOMICS INC (NEO)
CIK:        0001077183
Form:       8-K
Filed at:   2022-05-06T23:59:59+00:00
Accession:  0001077183-22-000076
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

NeoGenomics Pharma Services President Dr. Gina Wallar resigns; Jennifer Rose named interim lead
--------------------------------------------------------------------------------

- Dr. Gina M. Wallar resigns as President of Pharma Services Division effective May 27, 2022.
- Jennifer Rose, current VP of Pharma Sales and Project Management, will assume interim responsibility starting May 27, 2022.
- Ms. Rose joined NeoGenomics in December 2015.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1077183/000107718322000076/0001077183-22-000076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1077183/000107718322000076/neo-20220502.htm
  HTML page:      https://secwatch.observer/filing/0001077183-22-000076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer